Epstein Secrets

ynthetic Cannabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for. Compound 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 ng/mL CUMYL-THPINACA 0.10 ng/mL 5

upp ementa eport of ers & 002 and "Hospital or Medical Records" 005, 006, 007, 008, 009, 010, and 011. The following documents were received from the NYP Medical Correspondence Unit on 8/13 and uploaded to the file: "Hospital or Medical Records" 004, 012 & 013. The followin. documents were re • uested and received from James Sa

ynthetic Cannabinotds Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for aaranstuad Ret Limit COOMBS' Rot—Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 ng/m

, . upp emen a Report (others)" 001 & 002 and "Hospita or edical eco s , 007, 008, 009, 010, and 011. The following documents were received from the NYP Medical Correspondence Unit on 8/13 and uploaded to the file: "Hospital or Medical Records" 004, 012 & 013± The following received from James Saunders, Esq office, of the FDN

ynthetic Cannabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for Compound Rid I iat C.00.12011XL Rot Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 n

: "Supp ementa eport o ers 1 r & 002 and "Hospital or Medical ecor s , 007, 008, 009, 010, and 011. The following documents were received from the NYP Medical Correspondence Unit on 8/13 and uploaded to the file: "Hospital or Medical Records" 004, 012 & 013. The followin docume is were r and received from James Saunders, Es